Immunoglobulin G subclasses and susceptibility to allosensitization in humans

Clinical Nephrology

Volumn 48, Issue 3, 1997, Pages 165-172

  Okasha, K ^a   Saxena, A ^b   El Bedowey, M M ^a   Shoker, A S ^c,d  

^a TANTA UNIVERSITY   (Egypt)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

^c UNIVERSITY OF SASKATCHEWAN   (Canada)

^d ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Alloreactive antibody; B lymphocytes; Sensitization; Uremia

Indexed keywords

ALLOANTIGEN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; POKEWEED MITOGEN;

ADULT; ALLOIMMUNIZATION; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMORAL IMMUNITY; LYMPHOCYTE PROLIFERATION; LYMPHOCYTOTOXICITY; MALE; SENSITIZATION; T LYMPHOCYTE; UREMIA;

ADULT; B-LYMPHOCYTES; CASE-CONTROL STUDIES; CYTOTOXICITY TESTS, IMMUNOLOGIC; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; GRAFT REJECTION; HUMANS; IMMUNOGLOBULIN G; IMMUNOSUPPRESSION; KIDNEY TRANSPLANTATION; MALE; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS; UREMIA;

EID: 0030776887     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. 4 response. Int Arch Allergy Immunol 102: 347-351
2. 2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol 63: 127-134
3. Buelow R, Burlingham WJ, Clayberger C 1995 Immunomodulation by soluble HLA class I. Transplantation 59: 649-654
4. 3 antibodies in chronic hyperreactive oncho-dermatitis (Sowda). Clin Exp Immunol 74: 223-229
5. Charlton KK, Zmijewski CM 1970 Soluble HLA-A7 antigen: localization in the beta-lipoprotein fraction of human serum. Science 170:636-637
6. Datta SK, Schwanz KS 1978 Genetic, viral and immunologic aspects of autoimmune disease in NZB mice. In: Genetic Control of Autoimmune Disease. Kose NR, Bigazzi PE and Warner NL (eds). Elsevier-Biomedical Press, NY, p 193
7. Daverport A, Younie ME, Parsons JEM, Klouda PT 1994 Development of cytotoxic antibodies following renal allograft transplantation is associated with reduced graft survival due to chronic vascular rejection. Nephrol Dial Transplant 9: 1315-1319
8. Desai-Mehta A, Liangjun L, Ramsey-Goldman R, Dana SK 1996 Hyperexpression of CD40 ligand by B and T cells in human lupus and its role in pathogenic autoantibody production. J Clin Invest 97: 2063-2073
9. Duijvestijn AM, Van Breda Vriesman PJC 1991 Chronic renal allograft rejection: Selective involvement of the glomerular endothelium in humoral immune reactivity and intravascular coagulation. Transplantation 52: 195-202
10. Eisenberg RA, Dyer K, Craven SY, Fuller CR, Yount WJ 1985 Subclass restriction and polyclonality of the systemic lupus erythematosus marker antibody anti-Sm. J Clin Invest 75: 1270-1277
11. Ettenger RB, Terasaki PI, Ting A, Malekzadeh MH, Pennisi AJ, Uittenbogaart C, Garrison R, Fine RN 1976 Anti-B lymphocytotoxins in renal-allograft rejection. N Engl J Med 295: 305-309
12. Freijd A, Hammarstrom L, Persson MAA, Smith CIE 1984 Plasma antipneumococcal antibody activity of the IgG class and subclasses in otitis prone children. Clin Exp Immunol 56: 233-238
13. Fuller TC, Phelan D, Gebel HM, Rodey GE 1982 Antigenic specificity of antibody reactive in the antiglobulin-augmented lymphocytotoxicity test. Transplantation 34: 24-29
14. Gilland LK, Norris NA, Gorsmaire LS, Ferrone S, Gladstone P, Ledbetter JA 1989 Signal transduction in lymphocyte activation through crosslinking of HLA class I molecules. Hum Immunol 25: 269-289
15. Gjertson D 1991 Survival trends in long-term first cadaver-donor kidney transplants. In: Terasaki PI and Cecka JM (eds). Clinical Transplants. UCLA Tissue Typing Laboratory, Los Angeles, CA, pp 225-235
16. 1 subclass: a ling with Sjogren's syndrome. Ann Rheum Dis 49: 373-377
17. Izuis L, Eisenberg RA, Dixon FJ 1981 Subclass restricted polyclonal antibody production in mice injected with lipid A rich lipopolysaccharides. J Exp Med 153: 324-338
18. Kay RA, Wood KJ, Bernstein RM, Holt PJL, Pumphrey RSH 1988 An IgG subclass imbalance in connective tissue disease. Ann Rheum Dis 47: 536-541
19. Keown PA 1987 The highly sensitized patient: Aetiology, impact and management. Transplant Proc 19: 74-78
20. Kerman RH, Susskind B, Buelow R, Regan J, Pouletty P, Williams J, Gerolami K, Kerman DH, Katz SM, Van Buren CT, Kahan BD 1996 Correlation of Elisa-detected IgG and IgA anti-HLA antibodies in pretransplant sera with renal allograft rejection. Transplantation 62: 201-205
21. Kissmeyer-Nielsen F, Olsen F, Petersen VP, Fjeldborg O 1966 Hyperacute rejection of kidney allograft associated with pre-existing humoral antibodies against donor cells. Lancet 1: 662-665
22. Klinman NR 1996 In vitro analysis of the generation and propagation of memory B cell. Immunol Rev 150: 91-111
23. Klinman DM, Steinberg AD 1987 Autoimmune disorders. In: Lahita RG (ed). Systemic Lupus Erythematosus Textbook. John Wiley and Sons, NY, p 1
24. Klinman DM, Steinberg AD 1987 Systemic autoimmune disease arises from polyclonal B cell activation. J Exp Med 165: 1755-1760
25. 1 (A1) syndrome" is a secondary phenomenon due to autoimmune disease. Hum Genet 84: 491
26. Lanzuvecchia A, Parodi B, Celada F 1983 Activation of human B lymphocytes: Frequency of antigen specific B cells triggered by alloreactive or antigen-specific T cell clones. Eur J Immunol 13: 733-738
27. Ludwin D, Joseph S, Singal DP 1986 MLC-inhibiting antibodies in mice after blood transfusions. Transplantation 41: 100-104
28. Merino R, Iwamoto M, Fossati L, Izui S 1993 Polyclonal B cell activation arises from different mechanisms in lupus-prone (NZB X NZW)F1 and MRL/MpJ-Ipr/Ipr Mice. J Immunol 151: 6509-6516
29. Mohanakumar T, Waldrep JC, Phibs M, Mendez-Piccon G, Kaplan AM, Lee HM 1981 Serological characterization of antibodies eluted from chronologically rejected human renal allografts. Transplantation 32: 61-66
30. Moller G 1993 Chronic graft rejection. In: Immunological Reviews. Munksgaard International Publishers Ltd., Copenhagen, Denmark, pp 134
31. Mond JJ, Lee A,. Snapper CM 1995 T cell independent antigen type 2. Annu Rev Immunol 13: 655-692
32. Monos DS, Prystowsky MB, Levinson AI, Zmijewski CM 1988 Evaluation of B-cell immunity in patients with pretransplant sensitization. J Clin Immunol 8: 200-206
33. Moretta A, Accolla RS, Cerottini JC 1982 IL-2 mediated T cell proliferation in humans is blocked by a monoclonal antibody directed against monomorphic determinants of HLA-DR antigens. J Exp Med 15: 599-604
34. Mosier DE, Subbarao B 1982 Thymus-independent antigens: complexity of B-lymphocyte activation revealed. Immunol Today 3: 217-222
35. Palmer A, Bewick M, Kennedy L, Welsh K, Taube D 1989 Anti-HLA antibodies following the transplantation of highly sensitized renal allograft recipients. Transplant Proc 21: 766-767
36. Phelan DL, Rodey GE, Anderson CB 1989 The development and specificity of antiidiotypic antibodies in renal transplant recipients receiving single-donor blood transfusions. Transplantation 48: 57-60
37. Prud'homme GJ, Bolderas RS, Dixon FJ, Theofilopoulos AN 1983 B cell dependence on and response to accessory signals in murine lupus strains. J Exp Med 157: 1815
38. Quinn SM, Zhang JB, Gunsolly JC, Schenkein HA, Tew JG 1996 Influence of smoking and race on immunoglobulin G subclass concentration in early onset periodentitis patients. Infect Immun 64: 2500-2505
39. Reison WF, Skvaril F, Braun DG 1976 Natural infection of man with group A streptococci. Levels, restrictions in class, subclass and type and clonal appearance of polysaccharide group specific antibodies. Scand J Immunol 5: 383-390
40. Scott MG, Shackelford PG, Brile DE, Nahm MH 1988 Human IgG subclasses and their relation to carboyhdrate antigen immunocompetence. Diagnost Clin Immunol 5: 241-248
41. 2 subclass deficiency. Lancet 340: 448-450
42. Shaker AS, Sheridan D, Kalra J 1995 The differential effect of alloantigen-blocking antibodies on unprimed and memory T helper cells. Transplantation 60: 184-191
43. Shaker A, Miller R, Uldall R, Friedman E, Angra S, Cordelia CJ 1995 Lack of enhanced T-helper cell function in uremic patients with circulating alloreactive antibodies. J Am Soc Neph 5: 1441-1450
44. Singal DP, Blajchman MA, Joseph S, Roberge B, Smith EKM, Ludwin D 1988 Production in vitro of antibodies directed against alloantigen-specific recognition sites on T cells and on lymphocytotoxic HLA antibodies. Clin Exp Immunol 72: 222-227
45. Slack J, DerBalian GP, Nahm M, Davie JM 19SO Subclass restriction of murine antibodies. II. The IgG plaque forming cell response to thymus independent type 1 and 2 antigens in normal mice and mice expressing and x-linked immunodeficiency. J Exp Med 151: 853-862
46. Slack JH, Davie JH 1982 Subclass restriction of murine antibodies.V. The IgG plaque-forming cell response to thymus-independent and thymus dependent antigens in athymic and euthymic mice. Cell Immunol 68: 139-145
47. Snapper CM, Mond JJ 1996 A model for induction of T cell independent humoral immunity in response to polysoccharide antigens. J Immunol 157: 2229-2233
48. Stemberg JC 1977 A rate nephelometer for measuring specific proteins by immunoprecipitin reactions. Clin Chem 23: 1456
49. Stevens R, Dichek D, Keld B, Heiner D 1983 IgG, is the predominant subclass of in vivo- and in vitro-produced anti-tetanus toxoid antibodies and also serves as the membrane IgG molecule for delivering inhibitory signals to anti-tetanus toxoid antibody-producing B cells. J Clin Immunol 3: 65-69
50. Suthanthiran M, Strom TB 1994 Renal transplantation. N Engl J Med 331 (6): 365-376
51. Taylor CJ, Chapman JR, Tng R, Morris PJ 1989 Characterization of lymphocytoxic antibodies causing a positive crossmatch in renal transplantation. Transplantation 48: 953-958
52. Taylor DS, Nowell PC, Kornbluth J 1986 Functional role of HLA class I cell-surface molecules in human T-lymphocyte activation and proliferation. Proc Natl Acad Sci USA 83: 4446-4450
53. Theofilopoulos AN, Dixon FJ 1981 Etiopathogenesis of murine systemic lupus erythematosus. Immunol Rev 55: 179
54. Urban ND, Zier KS 1991 Negative signal transmission through class II molecules on activated T cells. Hum Immunol 31: 170-179
55. Van Vunakis H, Langone JJ (eds) 1980 In: Immunochemical Techniques. Methods Enzymol 70: 419-439
56. Weimer R, Zipperle S, Daniel V Pomer S, Staehler G, Opel: G 1992 In vitro B cell response in long-term renal transplant recipients. Transplantation Proc 24: 2537-2538
57. Weimer R, Daniel V, Pomer S, Opelz G 1989 B lymphocyte response as an indicator of acute renal transplant rejection. I. Immunoglobulin-secreting cells in peripheral blood. Transplantation 48: 569-572
58. Wieneke H, Otte B, Lang D, Heidenreich S 1996 Predictive value of IgG subclass levels for infectious complications in renal transplant recipients. Clin Nephrol 45: 22-28
59. Yarchoan R, Redfield RR, Broder S 1986 Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. J Clin Invest 78: 439-447
60. 2. Infect Immun 63: 3772-3779
61. Young AJ, Hay JB, MacKay CR 1993 Lymphocyte recirculation and life span in vivo. Curr Top Microbiol Immunol 184: 161-173